Egrie JC - Search Results

1

A comparison of the responses to recombinant human erythropoietin in normal and uremic subjects.

Eschbach JW, Haley NR, Egrie JC, Adamson JW. Eschbach JW, et al. Among authors: egrie jc. Kidney Int. 1992 Aug;42(2):407-16. doi: 10.1038/ki.1992.302. Kidney Int. 1992. PMID: 1405323 Free article. Clinical Trial.

2

USA multicenter clinical trial with recombinant human erythropoietin (Amgen). Results in hemodialysis patients.

Eschbach JW, Downing MR, Egrie JC, Browne JK, Adamson JW. Eschbach JW, et al. Among authors: egrie jc. Contrib Nephrol. 1989;76:160-5; discussion 212-8. doi: 10.1159/000417892. Contrib Nephrol. 1989. PMID: 2684518 Clinical Trial. No abstract available.

3

The anemia of end-stage renal disease: hematopoietic progenitor cell response.

Segal GM, Eschbach JW, Egrie JC, Stueve T, Adamson JW. Segal GM, et al. Among authors: egrie jc. Kidney Int. 1988 May;33(5):983-8. doi: 10.1038/ki.1988.97. Kidney Int. 1988. PMID: 3392887 Free article.

4

Identification of the receptor for erythropoietin on human and murine erythroleukemia cells and modulation by phorbol ester and dimethyl sulfoxide.

Broudy VC, Lin N, Egrie J, de Haën C, Weiss T, Papayannopoulou T, Adamson JW. Broudy VC, et al. Proc Natl Acad Sci U S A. 1988 Sep;85(17):6513-7. doi: 10.1073/pnas.85.17.6513. Proc Natl Acad Sci U S A. 1988. PMID: 2842774 Free PMC article.

5

The safety of epoetin-alpha: results of clinical trials in the United States.

Eschbach JW, Egrie JC, Downing MR, Browne JK, Adamson JW. Eschbach JW, et al. Among authors: egrie jc. Contrib Nephrol. 1991;88:72-80. doi: 10.1159/000419517. Contrib Nephrol. 1991. PMID: 2040198 Clinical Trial. No abstract available.

6

Recombinant human erythropoietin in anemic patients with end-stage renal disease. Results of a phase III multicenter clinical trial.

Eschbach JW, Abdulhadi MH, Browne JK, Delano BG, Downing MR, Egrie JC, Evans RW, Friedman EA, Graber SE, Haley NR, et al. Eschbach JW, et al. Among authors: egrie jc. Ann Intern Med. 1989 Dec 15;111(12):992-1000. doi: 10.7326/0003-4819-111-12-992. Ann Intern Med. 1989. PMID: 2688507 Clinical Trial.

7

Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trial.

Eschbach JW, Egrie JC, Downing MR, Browne JK, Adamson JW. Eschbach JW, et al. Among authors: egrie jc. N Engl J Med. 1987 Jan 8;316(2):73-8. doi: 10.1056/NEJM198701083160203. N Engl J Med. 1987. PMID: 3537801 Clinical Trial.

8

Intravenous versus subcutaneous dosing of epoetin alfa in hemodialysis patients.

Paganini EP, Eschbach JW, Lazarus JM, Van Stone JC, Gimenez LF, Graber SE, Egrie JC, Okamoto DM, Goodkin DA. Paganini EP, et al. Among authors: egrie jc. Am J Kidney Dis. 1995 Aug;26(2):331-40. doi: 10.1016/0272-6386(95)90654-1. Am J Kidney Dis. 1995. PMID: 7645538 Free article. Clinical Trial.

9

The use of recombinant human erythropoietin (EPO) to correct the anemia of end-stage renal disease: a progress report.

Adamson W, Egrie JC, Browne JK, Downing MR, Eschbach W. Adamson W, et al. Among authors: egrie jc. Behring Inst Mitt. 1988 Aug;(83):188-92. Behring Inst Mitt. 1988. PMID: 3071336 Clinical Trial.

10

Effects of recombinant human erythropoietin and interleukin-3 on erythropoietic recovery from acute anemia.

Rosen BS, Levine EA, Egrie JC, Sehgal LR, Greenberg R, Rosen AL, Levine HD, Gould SA. Rosen BS, et al. Among authors: egrie jc. Exp Hematol. 1993 Oct;21(11):1487-91. Exp Hematol. 1993. PMID: 8405228

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

48 results

Search Page

Filters